10 Best Up And Coming Stocks To Own For 2016: Medtronic Inc (MDT)
Medtronic, Inc. (Medtronic), incorporated on April 23, 1957, is engaged in medical technology - alleviating pain, restoring health, and extending life for millions of people worldwide. As of April, 27, 2012, the Company functions in two operating segments that manufacture and sells device-based medical therapies. The Company's operating segments include Cardiac and Vascular Group, which consists of Cardiac Rhythm Disease Management (CRDM) and CardioVascular, and Restorative Therapies Group, which consists of Spinal, Neuromodulation, Diabetes and Surgical Technologies. Medtronic serves hospitals, physicians, clinicians, and patients in more than 120 countries worldwide. The Company's primary customers include hospitals, clinics, third-party health care providers, distributors, and other institutions, including governmental health care programs and group purchasing organizations. In August 2013, Medtronic, Inc. announced the closing of the acquisition of Cardiocom. Effective September 3, 2013, Medtronic Inc acquired a 30% stake in NGC Medical SpA.
Cardiac Rhythm Disease Management
CRDM develops, manufactures, and markets products for the diagnosis, treatment, and management of heart rhythm disorders and heart failure, including implantable devices, leads and delivery systems, products for the treatment of atrial fibrillation (AF), and information systems for the management of patients with CRDM devices. The Company's principal products offered by CRDM business include Implantable Cardiac Pacemakers (Pacemakers), Implantable Cardioverter Defibrillators (ICDs), Implantable Cardiac Resynchronization Therapy Devices (CRT-Ds and CRT-Ps), AF Products, Diagnostics and Monitoring Devices and Patient Management Tools. The Company's pacemaker systems are compatible with certain magnetic resonance imaging (MRI) machines. This includes the Revo MRI SureScan with United States Food and Drug Administration approval and the Advisa and Ensura MRI SureScan models with Conformite Europeene (CE)! Mark approval. Medtronic also continues to market the Adapta product family, which includes the Adapta, Versa, Sensia, and Relia models.
The Medtronic ICDs is the Protecta family with SmartShock technology, including the Lead Integrity Alert, a technology designed to improve the detection of lead fractures. Devices in the ICD family are the Protecta XT, Protecta, Cardia, and Egida models. Medtronic also continues to market the Secura and Maximo II devices. The Medtronic CRT-Ds is the Protecta family with SmartShock technology, including Protecta XT and Protecta, and the CRT-P devices are Consulta and Syncra. Medtronic also continues to market the Consulta, Cardia, Egida, and Maximo II CRT-D devices. In addition to these devices, Medtronic has an offering of left heart leads and delivery catheters with its Attain family of products. The Company's portfolio of AF products includes the Arctic Front Cardiac CryoAblation Catheter designed to treat paroxysmal AF by performing pulmonary vein isolation. The Company also offers the Reveal XT Insertable Cardiac Monitor, which is designed to identify and quantify episodes of AF. The Reveal DX and Reveal XT Insertable Cardiac Monitors devices are used to record the heart's electrical activity before, during, and after transient symptoms such as syncope and palpitations to help provide a diagnosis. It has a number of patient management tools, such as CareLink, Paceart, and CardioSight Service. CareLink enables patients to transmit data from their pacemaker, ICD, CRT-D, or Insertable Cardiac Monitors using a portable monitor that is connected to a standard telephone line or cellular network using the Medtronic M-Link accessory.
The Company competes with St. Jude Medical, Inc., Boston Scientific Corporation, Biotronik, Inc. and Sorin Group.
CardioVascular
CardioVascular is comprised of three businesses: Coronary, Endovascular and Peripheral, and Structural Heart. The Coronary business includes therapies to treat ! coronary ! artery disease (CAD) and hypertension. The products contained within this business include coronary stents and related delivery systems, along with a broad line of balloon angioplasty catheters, guide catheters, guidewires, diagnostic catheters, and accessories. The products offered by its Coronary business include Percutaneous Coronary Intervention (PCI) and Renal Denervation. The Endovascular and Peripheral business is comprised of a range of products and therapies to treat abdominal and thoracic aortic aneurysms and peripheral vascular disease (PVD). The Company's products include endovascular stent graft systems, embolic protection systems, and stent systems for the treatment of narrowed iliac arteries. The products offered by the Company's Endovascular and Peripheral business include Endovascular Stent Grafts and Peripheral Vascular Intervention (PVI). The Structural Heart business offers a range of products and therapies to treat a variety of heart valve disorders. The Company's products include products for the repair and replacement of heart valves, perfusion systems, positioning and stabilization systems for beating heart revascularization surgery, and surgical ablation products. The Company's principal products offered by its Structural Heart business include Heart Valves, Transcatheter Heart Valves, Arrested Heart Surgery, Beating Heart Surgery and Surgical Ablation.
The Company competes with Abbott Laboratories, Boston Scientific, and Johnson & Johnson, Cook, Inc., W. L. Gore & Associates, Inc., Endologix, Inc., C.R. Bard, Inc., Edwards LifeSciences Corporation, St. Jude, Terumo Medical Corporation and Sorin Group.
Spinal
The Company's Spinal business develops, manufactures, and markets a range of medical devices and implants used in the treatment of the spine and musculoskeletal system. The Company's products and therapies treat a range of conditions affecting the spine, including degenerative disc disease, spinal deformity, spinal tumours, fractures ! of the sp! ine, and stenosis. The Company's Spinal business also provides biologic solutions for the dental and orthopedic markets. The Company's Spinal products are used in spinal fusion of both the thoracolumbar region, referring to the mid to lower vertebrae, as well as of the cervical region, or upper spine and neck vertebrae. Products used to treat spinal conditions include rods, pedicle screws, hooks, plates, and interbody devices, as well as biologics products, primarily bone growth substitutes including bone graft extenders and structural allografts such as dowels and wedges. The products offered by the Company's Spinal business include Thoracolumbar Products, Cervical Products and Biologics Products.
The Company competes with DePuy Spine, Inc., Synthes, Inc., Stryker Corporation, NuVasive, Inc., Globus Medical, Inc., Zimmer, Inc., Alphatec Spine, Inc., Orthofix International N.V., Biomet, Inc. and Johnson & Johnson.
Neuromodulation
The Company's Neuromodulation business develops, manufactures, and markets medical devices for the treatment of chronic pain, movement disorders, psychological disorders, and urological, fecal, and gastroenterological disorders. The l products offered by the Company's Neuromodulation business includes Neurostimulators for Chronic Pain, Implantable Drug Delivery Systems, Deep Brain Stimulation (DBS) Systems and Urology, Fecal, & Gastroenterology Devices. The Company's portfolio of products includes the RestoreSensor (rechargeable), with the Company's AdaptiveStim technology, as well as the RestoreULTRA (rechargeable), RestoreADVANCED (rechargeable), and PrimeADVANCED (non-rechargeable) neurostimulation systems. The SynchroMed II Programmable Infusion System delivers small quantities of drug directly into the intrathecal space surrounding the spinal cord. These devices are used to treat chronic, intractable pain and severe spasticity associated with cerebral palsy, multiple sclerosis, spinal cord and traumatic brain injuries, and stroke.
DBS uses a surgically implanted medical device, similar to a cardiac pacemaker, to deliver carefully controlled electrical stimulation to precisely targeted areas in the brain. The Company's family of Activa Neurostimulators for DBS includes Activa SC (single-channel primary cell), Activa PC (dual channel primary cell), and Activa RC (dual channel rechargeable). The Company's therapeutic portfolio for urology and gastroenterology includes the InterStim Therapy System, which treats the symptoms of overactive bladder, urinary retention, and chronic fecal incontinence, and the Enterra Therapy System for the treatment of chronic nausea and vomiting caused by gastroparesis of diabetic or idiopathic origin for drug refractory patients.The Company's competes with Boston Scientific, St. Jude., Urologix, Inc. and Allergan.
Diabetes
The Company's Diabetes business develops, manufactures, and markets advanced, integrated diabetes management solutions that include insulin pump therapy, continuous glucose monitoring systems, and therapy management software. The products offered by the Company's Diabetes business includes Integrated Diabetes Management Solutions, Professional CGM and CareLink Therapy Management Software. Outside the United States, the Company offers its Paradigm Veo System, an integrated system that includes a Low Glucose Suspend feature that automatically suspends insulin delivery when glucose levels become too low. In the United States, the Company offers the Paradigm Revel System, which incorporates new CGM features, including predictive alerts that can give early warning to people with diabetes so they can take action to prevent dangerous high or low glucose events. Medtronic offers physicians a Professional CGM product called the iPro CGM and iPro2 Professional CGM. The Company offers Web-based therapy management software solutions, including CareLink Personal software for patients and CareLink Pro software, to helps patients and their health care prov! iders con! trol their diabetes.
The Company competes with DexCom, Inc., Insulet Corporation, Johnson & Johnson and Roche Ltd.
Surgical Technologies
The Company's Surgical Technologies business develops, manufactures, and markets products and therapies to treat diseases and conditions of the ear, nose, and throat (ENT) and certain neurological disorders. In addition, the business develops, manufactures, and markets image-guided surgery and intra-operative imaging systems that facilitate surgical planning during precision cranial, spinal, sinus, and orthopedic surgeries. The products offered by the Company's Surgical Technologies business includes ENT, Neurological Technologies, Navigation and Advanced Energy. The ENT products treat diseases and conditions, such as NIM Nerve Monitoring Systems, Fusion ENT Navigation System, Hydrodebrider Endoscopic Sinus Irrigation System, Meniett Device for Meniere's Disease, Pillar Procedure for Snoring and Sleep Apnea, and Repose System for Obstructive Sleep Apnea. The Neurological Technologies products treat certain neurological disorders and conditions, such as Midas Rex Spine Shaver, the Midas Rex MR7 Pneumatic Platform, the Midas Rex Legend EHS High Speed Surgical Drill, the Strata Family of Adjustable Valves for the treatment of Hydrocephalus, Duet External Drainage & Monitoring System, the IPC System, and the Subdural Evacuating Port System.
The Navigation products are used in cranial, spinal, sinus, and orthopedic surgeries, such as the StealthStation S7 Navigation and i7 Integrated Navigation Systems, the O-Arm 2D/3D Surgical Imaging System, and the PoleStar Surgical MRI System. The products make up the Advanced Energy business: PEAK Surgery System, a tissue dissection system that consists of the PEAK PlasmaBlade and the PULSAR Generator and is cleared for use in a variety of settings, including ENT, plastic reconstructive and general surgery; and the Aquamantys System, which uses patented Transcollation technology to ! provide h! aemostatic sealing of soft tissue and bone and is cleared for use in a range of surgical procedures, including orthopedic surgery, spine, solid organ resection and thoracic procedures.
The Company competes with Gyrus ACMI, Stryker Corporation, Johnson & Johnson, Integra LifeSciences Holdings Corporation, BrainLAB, Inc., GE Healthcare, Siemens Medical Solutions USA, Inc., Philips Medical Systems, Covidien and ArthroCare Corporation.
Advisors' Opinion:- [By Rich Smith]
Medtronic (NYSE: MDT ) is expanding its products for endovascular aortic repair in the U.S. with two new devices: the FDA-approved Endurant II Aorto-Uni-Iliac (AUI) Stent Graft System and the FDA 510(k)-cleared Sentrant Introducer Sheath.
- [By Dan Carroll]
As advanced markets mature, most big players in the industry will have to expand geographically. Orthopedics is hardly the only business feeling the heat from leading economies. Cardiovascular businesses have also been under fire lately, and Medtronic (NYSE: MDT ) , the biggest pure player in the medical device industry, has started its own push to expand around the globe. Medtronic hopes to generate 20% of total�sales from emerging markets by 2016, and the company's $816 million acquisition of Chinese orthopedics maker Kanghui Holdings last year is a step in the right direction.
Top Safest Companies To Invest In Right Now: Allot Communications Ltd.(ALLT)
Allot Communications Ltd. engages in developing, selling, and marketing Internet protocol service optimization and revenue generation solutions in Europe, the Middle East, Africa, the Americas, Asia, and Oceania. Its solutions are used to create policies to monitor network applications, enforce quality of service policies that guarantee mission-critical application performance, mitigate security risks, and leverage network infrastructure investments. The company offers traffic management systems, including Service Gateway platform for broadband service control and optimization based on DPI; and NetEnforcer traffic management system that inspects, monitors, and controls network traffic by application and by user. Its network management application suites comprise NetXplorer that provides service providers and enterprise customers a view of traffic on the network; and Subscriber Management Platform, a system that helps service providers build an intelligent service network d esigned to deliver the quality of experience. The company also offers ServiceProtector, which ensures service continuity, and guards network integrity against known and unknown threats, as well as enables surgical mitigation through immediate identification of denial of service attacks, zero day attacks, worms, zombie, and botnets. In addition, it provides MediaSwift that caches and accelerates popular Internet video. The company markets and sells its products to carriers, mobile operators, cable operators, educational institutions, governments, and enterprises, as well as wireless, wireline, and satellite Internet service providers. It sells it products through distributors, resellers, OEMs, value added resellers, and system integrators, as well as through direct sales. The company was formerly known as Ariadne Ltd. and changed its name to Allot Communications Ltd. in September 1997. Allot Communications Ltd. was founded in 1996 and is based in Hod-Hasharon, Israel.
Advisors' Opinion:- [By Jon C. Ogg]
Allot Communications Inc. (NASDAQ: ALLT) was raised to Outperform with an $18 price target at Oppenheimer.
Baxter International Inc. (NYSE: BAX) was added to the Conviction Buy list with an $86 price target at Goldman Sachs.
- [By Evan Niu, CFA]
What: Shares of Allot Communications (NASDAQ: ALLT ) have popped today by as much as 10% after the company scored a big contract.
So what: Allot said it landed a $6.5 million order from a "Tier-1" mobile operator in Europe, the Middle East, and Africa for Intelligent Steering and Value-Added Service licenses. The company added that the contract is a licensing expansion of an existing deployment. The customer will add functionalities to the current Allot Service Gateways deployment.
- [By Garrett Cook]
Telecommunications services shares gained around 0.25 percent in today’s trading. Top gainers in the sector included NQ Mobile (NYSE: NQ), Allot Communications (NASDAQ: ALLT), and SK Telecom Co (NYSE: SKM).
Top Safest Companies To Invest In Right Now: RMG Ltd (RMG)
RMG Limited is an Australia-based company engaged in mineral exploration for base metals. The Company�� projects include Kamarga Zinc, Kamarga Copper and Mcleans creek. The Kamarga project is within 50kms of bitumen road, slurry pipeline for concentrates to a port, and high-voltage electricity transmission line. During the fiscal year ended June 30, 2012, with the acquisition of the Kamarga zinc project and Zeehan leadzinc-silver project and management focus on these new acquisitions, the two tenements on the South Australian areas have been relinquished. The Company�� subsidiaries include Resource Mining Group Pty Ltd (formerly Springfield Minerals Pty Ltd), San Saba Pty Ltd, Sunlander Nominees Pty Ltd and Moonraker Minerals Pty Ltd. In April 2013, it announced the completion of acquisition of Symon Communications Holdings Corporation. Advisors' Opinion:- [By Inyoung Hwang]
Royal Mail (RMG) Group Ltd. jumped the most in a month after the U.K. postal service that listed its shares in October said first-half earnings almost doubled. Vivendi SA (VIV) advanced 1.9 percent after saying it will replace its chairman once it spins off its wireless business. Accor SA dropped 3.9 percent after saying it will separate the operation and ownership of hotels into two businesses.
- [By Joao Lima]
Portugal�� 78 billion-euro bailout package from the European Union and International Monetary Fund requires the government to dispose of assets to raise revenue. The U.K. sold a majority stake in British counterpart Royal Mail Plc (RMG) in October at a price that some lawmakers said was too low. Those shares jumped 38 percent in their trading debut.
Top Safest Companies To Invest In Right Now: Ishares Gold Trust (IAU)
ishares Gold Trust (the Trust), incorporated on January 21, 2005, is to own gold transferred to the Trust in exchange for shares issued by the Trust (Shares). Each Share represents a fractional undivided beneficial interest in the net assets of the Trust. The assets of the Trust consist of gold held by the Trust�� custodian on behalf of the Trust. The sponsor of the Trust is BlackRock Asset Management International Inc. (the Sponsor). The trustee of the Trust is The Bank of New York Mellon (the Trustee) and the custodian of the Trust is JPMorgan Chase Bank, N.A., London branch (the Custodian).
The activities of the Trust are limited to issuing Baskets of Shares in exchange for the gold deposited with the Custodian as consideration; selling gold as necessary to cover the Sponsor�� fee, Trust expenses not assumed by the Sponsor and other liabilities, and delivering gold in exchange for Baskets of Shares surrendered for redemption. It does not engage in any activities designed to obtain a profit from, or to ameliorate losses caused by, changes in the price of gold.
Advisors' Opinion:- [By Quoth the Raven]
The other common way to invest is through ETFs such as iShares Gold Trust (IAU), which basically track the price of the commodity by physically purchasing bullion. The ETFs asset price reflect the price as which it trades for. If the underlying asset is silver, the ETF trades proportional to what the silver's worth.
- [By Peter Pham]
Although the Fed doubled its bond buying last September, the top gold exchange-traded funds, or ETFs, including SPDR Gold Shares (NYSEMKT: GLD ) , iShares Gold Trust (NYSEMKT: IAU ) , and ETFS Physical Swiss Gold Shares (NYSEMKT: SGOL ) , have dropped around 25% each over the last 12 months, which speaks to gold's extreme vulnerability to QE tapering. Even the mere mention of tapering seems to send gold into a tailspin, as seen with SPDR Gold Shares, which has plunged 24% year to date and also suffered massive losses with its physical holdings. Market Vectors Gold Miners ETF (NYSEMKT: GDX ) has suffered a massive drop of 48% so far in 2013, making it one of the worst-performing ETFs this year.
- [By Sean Williams]
The first method is by purchasing an ETF that closely tracks the underlying price of gold. The iShares Gold Trust (NYSEMKT: IAU ) and SPDR Gold Shares (NYSEMKT: GLD ) are two easy ways of buying into an ETF that holds physical gold without having to go through a physical gold dealer and taking delivery of the product. Also, both ETFs are extremely liquid, which means that you can access your money through your favorite brokerage by buying or selling anytime you need. The downside, of course, is that physical gold offers no dividend yield, so it's all about the price appreciation potential here.
Top Safest Companies To Invest In Right Now: Glencore Xstrata PLC (GLCNF.PK)
Glencore Xstrata Plc is a diversified natural resource company. The Company operates in three segments: Metals and Minerals, which includes copper, nickel, zinc/lead, alloys, alumina/aluminum and iron ore; Energy Products, which includes controlled and non-controlled coal mining and oil production operations and investments in strategic handling, storage and freight equipment and facilities, and Agricultural Products, which focuses on grains, oils/oilseeds, cotton and sugar. The Company�� operations consist of over 150 mining and metallurgical sites, offshore oil production assets, farms and agricultural facilities. The Company is a producer and marketer of over 90 commodities, such as mobile phones, bicycles, cutlery, plastics and electricity. Effective January 2, 2014, Post Holdings Inc acquired Agricore United Holdings Inc from Viterra Inc, a unit of Glencore Xstrata PLC, and the transaction also included Dakota Growers Pasta Company, Inc. Advisors' Opinion:- [By Pendulum]
Century Aluminum was founded in 1995 as a part of Glencore (GLCNF.PK). In 1996, Century Aluminum became a public company. As of December 31, 2012:
"Glencore beneficially owned approximately 41.8% of our outstanding common stock and all of our outstanding Series A Convertible Preferred Stock. Through its ownership of common and preferred stock, Glencore has an overall 46.6% economic ownership of Century." (Source: Century Aluminum 2012 10-K)
Top Safest Companies To Invest In Right Now: Intuitive Surgical Inc.(ISRG)
Intuitive Surgical, Inc. designs, manufactures, and markets da Vinci surgical systems for various surgical procedures, including urologic, gynecologic, cardiothoracic, general, and head and neck surgeries. Its da Vinci surgical system consists of a surgeon?s console or consoles, a patient-side cart, a 3-D vision system, and proprietary ?wristed? instruments. The company?s da Vinci surgical system translates the surgeon?s natural hand movements on instrument controls at the console into corresponding micro-movements of instruments positioned inside the patient through small puncture incisions, or ports. It also manufactures a range of EndoWrist instruments, which incorporate wrist joints for natural dexterity for various surgical procedures. Its EndoWrist instruments consist of forceps, scissors, electrocautery, scalpels, and other surgical tools. In addition, it sells various vision and accessory products for use in conjunction with the da Vinci Surgical System as surgical procedures are performed. The company?s accessory products include sterile drapes used to ensure a sterile field during surgery; vision products, such as replacement 3-D stereo endoscopes, camera heads, light guides, and other items. It markets its products through sales representatives in the United States, and through sales representatives and distributors in international markets. The company was founded in 1995 and is headquartered in Sunnyvale, California.
Advisors' Opinion:- [By Matt Thalman]
Editor's note: This video was shot before Intuitive Surgical's (NASDAQ: ISRG ) recent earnings forecast, in which the stock fell more than 18% in one trading session. The chart presented during the video does not reflect that move.
- [By Brian Stoffel]
This year has been a bit of a roller coaster for investors in Intuitive Surgical (NASDAQ: ISRG ) . The company responsible for manufacturing and selling the daVinci Surgical Robot has had no problem continuing to grow its business, but a number of new worries have appeared on the horizon, causing Intuitive's stock to take a long pause.
Top Safest Companies To Invest In Right Now: Authentidate Holding Corp.(ADAT)
Authentidate Holding Corp. provides secure Web-based software applications and telehealth products and services in the United States. It offers Inscrybe Healthcare, a Web-based health information exchange and workflow automation solution that enables healthcare industry participants to exchange and track a range of documents, certificates, authorizations, and other information over various modes of communication, including electronic and fax delivery; Inscrybe Office, a Web-based service to sign, seal, and confirm receipt of important documents; and AuthentiProof, a content integrity and time-and-date stamp application. The company also provides the in-home ExpressMD solution, which integrates Electronic House Call in-home patient vital signs monitoring system with a software interface based on the Inscrybe Healthcare platform. It serves integrated delivery networks, physician groups and networks, managed care organizations, hospitals, medical centers, home health agencies , pharmacies, governments, and public health organizations through direct sales and reseller arrangements. The company was formerly known as Bitwise Designs, Inc. and changed its name to Authentidate Holding Corp. in March 2001. Authentidate Holding Corp. was founded in 1985 and is based in Berkeley Heights, New Jersey.
Advisors' Opinion:- [By James E. Brumley]
In a perfect world, a stock's price is merely a reflection of a predictable combination of a company's history and forward-looking prospects. We don't live - or trade - in a perfect world though. In the real world, a chart not only tells a story, but illustrates traders' changing opinion of a stock. The good news is, traders move, thing, buy, and sell in fairly predictable patterns, and when you see certain hints fall in place, you can make a very good trade. Enter Authentidate Holding Corp. (NASDAQ:ADAT) and Greenhunter Resources Inc. (NYSEMKT:GRH). Both GRH as well as ADAT have taken on a bullish shape as of today, and both are apt to be at much higher levels in the foreseeable future.
No comments:
Post a Comment